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Objective: To assess the prognostic value of dobutamine stress echocardiography (DSE) in patients with
previous myocardial revascularisation.
Design: Prospective study.
Setting: Tertiary referral centre in Rotterdam, the Netherlands.
Patients: 332 consecutive patients with previous percutaneous or surgical coronary revascularisation
underwent DSE. Follow up was successful for 331 (99.7%) patients. Thirty eight patients who underwent
early revascularisation ( 3 months) after the test were excluded from analysis.
Main outcome measures: Cox proportional hazards regression models were used to identify independent
predictors of the composite of cardiac events (cardiac death, non-fatal myocardial infarction, and late
revascularisation).
Results: During a mean (SD) of 24 (20) months, 37 (13%) patients died and 89 (30%) had at least one
cardiac event (21 (7%) cardiac deaths, 11 (4%) non-fatal myocardial infarctions, and 68 (23%) late
revascularisations). In multivariate analysis of clinical data, independent predictors of late cardiac events
were hypertension (hazard ratio (HR) 1.7, 95% confidence interval (CI) 1.1 to 2.6) and congestive heart
failure (HR 2.1, 95% CI 1.3 to 3.2). Reversible wall motion abnormalities (ischaemia) on DSE were
incrementally predictive of cardiac events (HR 2.1, 95% CI 1.3 to 3.2).
Conclusions: Myocardial ischaemia during DSE is independently predictive of cardiac events among
patients with previous myocardial revascularisation, after controlling for clinical data.
O
ver the past decade, advances in the invasive manage-
ment of patients with chronic coronary artery disease
have evolved dramatically. Thus, patients with pre-
vious coronary interventions constitute a growing subgroup
of patients referred for non-invasive testing to evaluate
symptoms or to rule out coronary restenosis, graft occlusion,
or progression of coronary artery disease. However, the clini-
cal utility of stress testing in the setting of prior surgical or
percutaneous coronary intervention has been questioned.1–3
Dobutamine stress echocardiography (DSE) has been
established as a safe, feasible, and accurate technique for
the detection of myocardial ischaemia and assessment of
prognosis for patients with known or suspected coronary
artery disease, particularly for patients who are unable to
perform an adequate exercise stress test.4–6 However, the
prognostic value of DSE for patients with previous coronary
revascularisation has not been established. Accordingly, the
aim of this study was to assess whether DSE has additive
prognostic value relative to clinical variables among patients
with previous coronary revascularisation.
METHODS
Patient population
The study population consisted of 332 consecutive patients
with previous coronary revascularisation. Patients were
unable to perform an exercise test because of orthopaedic
limitations, peripheral arterial or neurological diseases,
respiratory insufficiency, or deconditioning and they under-
went DSE in our centre. If patients underwent DSE more
than once after revascularisation, only the results of the first
test were included in the study. All patients were enrolled in
an electronic registry that accumulated in the course of daily
clinical care. Informed consent was given before testing. The
hospital ethics committee approved the protocol.
Clinical data
Before the dobutamine stress test, a structured interview and
clinical history, including assessment of cardiac risk factors,
were obtained. Congestive heart failure was assessed as any
current or previous signs or symptoms of breathlessness,
abnormal fluid retention, or both. Hypertension was defined
as a blood pressure of > 140/90 mm Hg or treatment
with antihypertensive medication. Diabetes mellitus was
defined as a fasting glucose concentration of > 140 mg/dl
(> 7.8 mmol/l) or the need for insulin or oral hypoglycaemic
agents. Hypercholesterolaemia was defined as total choles-
terol concentration of > 200 mg/dl (> 5.2 mmol/l) or treat-
ment with lipid lowering medication.
Dobutamine stress protocol
Dobutamine stress testing was performed according to a
standard protocol as previously reported.6 Dobutamine was
administered intravenously, starting at a dose of 10 mg/kg/
min for three minutes (5 mg/kg/min for patients with resting
left ventricular dysfunction). Incremental dobutamine doses
of 10 mg/kg/min were given at three minute intervals up to a
maximum dose of 40 mg/kg/min. If the test end point was not
reached at a dobutamine dose of 40 mg/kg/min, atropine (up
to 2 mg) was given intravenously. Blood pressure, heart rate,
and ECG were constantly monitored. Test end points were
achievement of the target heart rate (85% of maximum age
and sex predicted heart rate), horizontal or downsloping ST
segment depression . 2 mm at an interval of 80 ms after
the J point compared with baseline, severe angina, a
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systolic blood pressure fall . 40 mm Hg, blood pressure
. 240/120 mm Hg, or significant cardiac arrhythmia. An
intravenous b blocker was available to reverse the adverse
effects of dobutamine or atropine.
Stress echocardiography
Two dimensional echocardiographic images were acquired at
rest, during dobutamine stress, and during recovery. The
echocardiograms were recorded in a quad screen format. Two
experienced observers scored the echocardiograms according
to a standard 16 segment model as recommended by the
American Society of Echocardiography.7 Regional wall
motion and systolic wall thickening were scored on a five
point scale (1, normal; 2, mild hypokinesia; 3, severe
hypokinesia; 4, akinesia; 5, dyskinesia). Ischaemia was
defined as new or worsened wall motion abnormalities
during stress, indicated by an increase of wall motion score
> 1 grade(s) in > 1 segment(s). Ischaemia was not
considered to be present when akinetic segments at rest
became dyskinetic during stress. For each patient, a wall
motion score index was calculated at rest and at peak
dobutamine stress by dividing the sum of segments scored by
the total number of interpreted segments.
Follow up
Follow up data were obtained in 2003. The mean (SD) follow
up period was 24 (20) months. The current status was
determined by contacting the patient’s general practitioner
and by reviewing hospital records. The date of the last review
or consultation was used to calculate the follow up time. An
outcome event was the composite of cardiac death, non-fatal
myocardial infarction, and late (. 3 months) coronary
revascularisation. Cardiac death was defined as death caused
by acute myocardial infarction, significant cardiac arrhyth-
mias, or refractory congestive heart failure. Sudden death
occurring without another explanation was regarded as
cardiac death. Non-fatal myocardial infarction was defined
according to the guidelines of the joint European Society of
Cardiology/American College of Cardiology committee.8
Statistical analysis
Data were expressed as mean (SD) or number (%) and
compared by Student’s t test or the x2 test. Univariate and
multivariate Cox proportional hazards regression models
were used to identify independent predictors of late cardiac
events. The clinical variables that were entered into the
model were sex, age, history of previous myocardial infarc-
tion, current smoking, hypertension, hypercholesterolaemia,
heart failure, angina pectoris, and the use of b blockers,
diuretics, digoxin, calcium antagonists, and angiotensin
converting enzyme antagonists. The echocardiographic vari-
ables were fixed wall motion abnormalities, reversible wall
motion abnormalities, or both, achievement of target heart
rate, and typical angina or ST depression during the stress
test. Variables were selected in a stepwise forward selection
manner with entry and retention set at a significance level of
0.05. The incremental value of DSE over the clinical variables
in the prediction of events was assessed by adding various
echocardiographic data to clinical and stress test parameters.
The risk of a variable was expressed as a hazard ratio (HR)
with a corresponding 95% confidence interval (CI). The
probability of cardiac event-free survival was calculated by
the Kaplan-Meier method and the resulting curves were
compared by the log rank test.
RESULTS
Clinical and stress test results
Table 1 presents the clinical characteristics of patients.
During DSE there was a significant increase in heart rate
(from 74 (14) to 132 (15) beats/min, p , 0.001), whereas
systolic blood pressure did not change significantly (131 (24)
v 129 (24) mm Hg). The mean (SD) maximum dobutamine
dose was 37 (8) mg/kg/min. Atropine was added for 153
(52%) patients. Target heart rate was achieved by 252 (86%)
patients. Side effects during DSE were short runs of
ventricular tachycardia (, 10 complexes) in 10 (3%)
patients, ventricular tachycardia of > 10 complexes in three
(1%), transient atrial fibrillation in three (1%), and severe
hypotension (symptomatic or decrease in systolic blood
pressure of . 40 mm Hg) in four (1%). No patient experi-
enced myocardial infarction or life threatening rhythm
disorders.
Echocardiographic data
The test was abnormal (fixed or reversible wall motion
abnormalities or both) in 241 (82%) patients. Ischaemia
(new or worsening wall motion abnormalities) was detected
in 96 (33%) patients. Of these patients, 75 had resting wall
motion abnormalities as well.
Follow up data
Follow up was successful for 331 (99.7%) patients. The
decision for late revascularisation was based on the recur-
rence of symptomatic coronary artery disease or on the
occurrence of an acute coronary event (unstable angina,
acute myocardial infarction) at least three months apart from
the first post-revascularisation DSE.
Thirty eight patients who underwent coronary revascular-
isation within three months of DSE were excluded from
analysis because for these patients the decision to revascu-
larise might have been influenced by test results. Among the
remaining 293 patients, 37 (13%) died of any cause and 89
(30%) patients had at least one cardiac event; 21 (7%) pati-
ents had a cardiac death, 11 (4%) had a non-fatal myocardial
infarction, and 68 (23%) had a late revascularisation.
Predictors of cardiac events
Univariate predictors of the composite of cardiac events were
congestive heart failure (HR 2, 95% CI 1 to 3.8), wall motion
score index at rest (HR 2.7, 95% CI 1.4 to 5), wall motion
score index at peak (HR 2, 95% CI 1.2 to 3.3), reversible wall
motion defects (ischaemia) on DSE (HR 2.9, 95% CI 1.7 to
4.8), ST segment depression (HR 2.8, 95% CI 1.2 to 6.3), and
angina pectoris (HR 2, 95% CI 1.2 to 3.5) during the test.
Table 1 Baseline clinical characteristics of 293 patients
Characteristic
Mean (SD) or
number (%)
Age (years) 62 (11)
Men 217 (74%)
Hypertension 119 (40%)
Diabetes mellitus 97 (33%)
Smoking 97 (33%)
Hypercholesterolaemia 120 (41%)
Congestive heart failure 46 (16%)
Myocardial infarction 203 (69%)
Coronary angioplasty 174 (59%)
Coronary artery bypass surgery 171 (58%)
1 vessel disease 141 (48%)
2 vessel disease 94 (32%)
3 vessel or left main disease 58 (20%)
Complete revascularisation 202 (69%)
Incomplete revascularisation 91 (31%)
Medication
b Blockers 127 (43%)
ACE inhibitors 128 (44%)
Calcium antagonists 121 (41%)
ACE, angiotensin converting enzyme.
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Multivariate predictors were hypertension (HR 1.7, 95% CI
1.1 to 2.6), congestive heart failure (HR 2.1, 95% CI 1.3 to
3.2), ischaemia on DSE (HR 2.1, 95% CI 1.3 to 3.2) (fig 1),
and ST segment depression on DSE (HR 2, 95% CI 1.1 to 3.8).
Among patients with ischaemia on DSE, those who had had
a coronary intervention , 2 years before the test had a
trend towards more cardiac events compared with patients
who had undergone revascularisation . 2 years before
(p = 0.09) (fig 2). The adverse outcome for patients with
ischaemia was equal irrespective of the presence or absence
of angina before the test (fig 3).
Predictors of cardiac death
Univariate predictors of cardiac death were diabetes mellitus
(HR 3.6, 95% CI 1.2 to 11.4) and congestive heart failure (HR
6.8, 95% CI 2.8 to 16.3). The same predictors were found after
multivariate analysis (HR 4.9, 95% CI 1.4 to 17.3 for diabetes
mellitus and HR 10.5, 95% CI 3.8 to 29.3 for congestive heart
failure).
Predictors of hard events
The only predictor of hard events (cardiac death plus
myocardial infarction) was congestive heart failure (HR 4.7,
95% CI 2.3 to 9.6 in univariate analysis and HR 8.1, 95% CI
3.5 to 18.5 in multivariate analysis).
DISCUSSION
We assessed the independent value of DSE for prediction of
cardiac events in 331 patients with previous revascularisation.
During a mean period of 24 (20) months, 89 patients had at
least one late cardiac event. The presence of congestive heart
failure predicted cardiac death or myocardial infarction,
whereas diabetes mellitus was an independent predictor of
cardiac death. Clinical predictors of cardiac events were
hypertension and congestive heart failure. Ischaemia on DSE,
indicated by either reversible wall motion abnormalities or ST
segment depression, was associated with increased risk of
cardiac events after controlling for clinical parameters.
According to the classic ischaemic cascade, ST segment changes
follow perfusion and wall motion abnormalities on imaging
stress testing. However, Picano9 has proposed an alternative
ischaemic cascade when endothelial dysfunction and impaired
coronary flow reserve are present without significant epicardial
coronary artery lesions. According to this model, ST segment
changes come first, perfusion abnormalities come second, and
echocardiographic changes are usually absent in the case of
milder, ‘‘patchy’’ degrees of myocardial ischaemia. Hence,
coronary endothelial dysfunction and impaired flow reserve
are likely to have an adverse effect on prognosis after coronary
revascularisation.
The risk associated with myocardial ischaemia was
observed among patients who had their revascularisation
performed within two years, as well as among patients who
had been revascularised . 2 years before DSE.
Impact of symptoms on outcome
Restenosis is the major limitation of coronary interventions.
It occurs usually within several months after a successful
Figure 1 Kaplan-Meier curves for
cardiac events (cardiac death, non-fatal
myocardial infarction, late
revascularisation) as a function of
dobutamine stress echocardiography
(DSE) results. Event-free survival
differed significantly between patients
with and patients without reversible wall
motion defects (ischaemia).
Figure 2 Kaplan-Meier curves for
cardiac events (cardiac death, non-fatal
myocardial infarction, late
revascularisation) as a function of DSE
results. Among patients with reversible
wall motion defects (ischaemia) event-
free survival did not differ significantly
between patients who were
revascularised . 2 years and patients
who were revascularised , 2 years
before the test. NS, not significant.
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percutaneous coronary intervention, with an incidence as
high as 33% in some patient subsets.10 After coronary bypass
surgery, the atherosclerotic process increases over the years,
leading to vein graft patency of , 65% 10 years after
surgery.11 According to the guidelines of the American
College of Cardiology/American Heart Association, stress
testing is recommended after coronary revascularisation only
for patients with recurrent symptoms that suggest ischaemia
(class I) or as part of cardiac rehabilitation (class IIa).12
However, symptoms after revascularisation are commonly
atypical and they cannot be considered to be reliable
determinants of restenosis or graft occlusion. The usefulness
of non-invasive imaging for asymptomatic patients after
coronary revascularisation has been questioned in previous
studies. Lauer and colleagues13 studied 873 symptom-free
patients after coronary artery bypass grafting by exercise
thallium-201 and found that thallium perfusion defects and
impaired exercise capacity were strong and independent
predictors of death or non-fatal myocardial infarction. Sarda
and colleagues14 found an independent predictive value of
201Tl myocardial scintigraphy after coronary artery bypass
grafting in a patient population consisting mainly of patients
who were asymptomatic before the test. In the present study,
the presence of angina pectoris before the test was not
associated with more cardiac events among patients with
reversible wall motion abnormalities on DSE. Consequently,
physicians cannot rely on symptoms after revascularisation to
determine the risk for future cardiac events. Evidence of
reversible wall motion abnormalities during dobutamine
stress predicts which patients are at a high risk of developing
late cardiac events, even if they are asymptomatic after a
coronary intervention. A more aggressive treatment may be
justified for these patients.
Comparison with previous studies
Authors of a large number of studies have reported on the
incremental prognostic value of DSE in the general popula-
tion,1 2 4–6 as well as in particular patient subsets.15–20 To our
knowledge, this is the first study to assess the prognostic
value of DSE for patients with prior coronary revascularisa-
tion. However, exercise echocardiography has been found to
predict cardiac events among patients after coronary artery
bypass surgery.21 In addition, several studies have reported
the prognostic value of nuclear scans for previously reva-
scularised patients. Palmas and colleagues22 found an
incremental prognostic value of 201Tl for 294 patients > 5
years after coronary artery bypass graft surgery. Miller and
associates23 reported a similar prognostic value for 201Tl
within two years after surgical revascularisation. In other
studies, 201Tl was predictive of cardiac events for patients 1–3
years after coronary angioplasty24 and for patients early (5 (2)
months) after coronary stenting.25 The present findings
indicate that DSE can alternatively be used as a prognostic
tool for these patients.
Study limitations
Readers of DSE results were not blinded to clinical informa-
tion and data concerning previous revascularisations.
Additionally, physicians were free to modify treatment
according to DSE results. Thus, administration of medication
that has been proved to reduce cardiac events and improve
outcome, such as b blockers and angiotensin converting
enzyme inhibitors, might have influenced patient prognosis.
Finally, our results were obtained in a single centre with a
high volume and experience with DSE; hence, our results do
not necessarily apply to other, less experienced centres.
Conclusions
DSE provides incremental data to the clinical information on
the prognosis of patients after revascularisation. Evidence of
myocardial ischaemia, based on reversible wall motion
abnormalities during dobutamine infusion, is an indepen-
dent predictor of cardiac events.
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Aortic arch aneurysm
A
68 year old man was admitted to
hospital for an ischaemic stroke.
His medical history revealed
hypertension, diabetes mellitus, chronic
atrial fibrillation, and a blunt trauma
sustained during a motor vehicle acci-
dent. Routine chest x ray revealed an
enlarged superior mediastinal silhouette
(left panel). Subsequently, magnetic
resonance imaging (MRI) showed a
thoracic saccular aneurysm of the aortic
arch with involvement of the branches
(right panel).
Transverse arch aneurysms are rela-
tively uncommon, comprising only 11%
of all aortic aneurysms. Saccular thor-
acic aneurysms are frequently post-
traumatic (high speed deceleration acci-
dents); other causes include syphilis,
autoimmune disorders, and athero-
sclerosis. The most frequently involved
location is the relatively immobile isth-
mus just distal to the origin of the left
subclavian artery, adjacent to the attach-
ment of the ligamentum arteriosus.
Many thoracic aneurysms are visible
on chest x ray and are characterised by
widening of the mediastinal silhouette,
enlargement of the aortic knob or
displacement of the trachea of the mid-
line.
However, saccular aneurysms may
not be evident on the chest x ray.
MRI is useful in detecting aneurysms
and especially magnetic resonance
angiography may prove to be useful in
defining the anatomy of aortic branch
vessels. The aneurysm in this patient
may be caused by atherosclerotic disease
and/or his deceleration trauma.
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